Name
Jelmyto
Alternate Names
mitomycin gel
Abbreviations
None
Category
Chemotherapy
Subcategory
Alkylating agent
anti neoplastic antibiotic
NSC Number
None
Primary Site
Bladder
Histology
None
Remarks
April 15, 2020 The FDA approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system.
Coding
This drug should be coded
Home